3/26/2014 9:20:46 AM
SOUTH SAN FRANCISCO, Calif., March 25, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today provided a corporate update and reported financial results for the fourth quarter and year ended Dec. 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by